[CTXR] YoY Quarter Result on 30-Jun-2020 [#Q3]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
14-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q3]
Profit Trend
QoQ- -5.76%
YoY- -6.22%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,335 -8,864 -5,824 -4,680 -4,406 -2,022 -2,422 22.86%
Tax 144 -53 63 13 25 0 34 27.18%
NP -8,479 -8,811 -5,824 -4,680 -4,406 -2,022 -2,422 23.21%
Tax Rate - - - - - - - -
Total Cost 8,479 8,811 5,824 4,680 4,406 2,022 2,422 23.21%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.06 -0.06 -0.04 -0.11 -0.20 -0.19 -0.48 -29.27%
EPS Diluted -0.06 -0.06 -0.04 -0.11 -0.20 -0.19 -0.48 -29.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.